Published in

Elsevier, The Lancet Respiratory Medicine, 10(5), p. 785-794, 2017

DOI: 10.1016/s2213-2600(17)30305-3

Links

Tools

Export citation

Search in Google Scholar

Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Journal article published in 2017 by Hossein-Ardeschir Ghofrani, Gérald Simonneau, Andrea M. D'Armini, Peter Fedullo, Luke S. Howard, Xavier Jaïs, David P. Jenkins, Zhi-Cheng Jing, Michael M. Madani, Nicolas Martin, Eckhard Mayer, Kelly Papadakis, Dominik Richard, Nick H. Kim, Irene Lang and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO